CD34 Enrichment & Hematopoietic Stem Cell Therapy | Genestac Therapeutics

What is CD34 Enrichment?

CD34 Enrichment is a specialized laboratory technique used to isolate CD34+ hematopoietic stem cells from bone marrow, peripheral blood, or umbilical cord blood. These stem cells are essential for generating new blood cells, repairing tissues, and supporting regenerative medicine. By enriching CD34+ cells, clinicians enhance the success of stem cell therapy and other advanced treatments.

What are CD34+ Hematopoietic Stem Cells?

• Hematopoietic Stem Cells (HSCs): CD34+ cells give rise to red blood cells, white blood cells, and platelets.
• Marker of Regeneration: CD34 is a key surface protein used in stem cell isolation for regenerative therapies.
• Multipotent Potential: These cells migrate to damaged tissues, reduce inflammation, and promote healing.

How CD34 Enrichment Works

• Step 1 – Cell Collection: Harvested from bone marrow, peripheral blood, or umbilical cord blood.
• Step 2 – Separation: CD34+ stem cells are isolated using magnetic-activated cell sorting (MACS) or fluorescence-activated cell sorting (FACS).
• Step 3 – Enrichment: The purified CD34+ population is concentrated for clinical use.

Clinical Applications of CD34 Enrichment

• Bone Marrow Transplantation: Treats blood cancers like leukemia and lymphoma.
• Cardiovascular Repair: Supports blood vessel regeneration in ischemic heart disease and PAD.
• Neurological Disorders: Aids recovery in ALS, Parkinson’s, and spinal cord injuries.
• Wound Healing: Enhances angiogenesis in chronic wounds and diabetic ulcers.

Advantages of CD34 Enrichment

• High Purity: Delivers targeted regenerative cells with reduced rejection risk.
• Personalized Therapy: Enables patient-specific stem cell therapy.
• Enhanced Efficacy: Optimized enrichment improves treatment outcomes.
• Reduced Side Effects: Safer compared to non-enriched bone marrow transplants.

Safety & Innovation

All CD34 Enrichment procedures are performed under GMP-certified conditions using advanced technologies like MACS and FACS. The process ensures viability, sterility, and precision dosing for safe clinical applications. Learn more from NCBI Stem Cell Research.

CD34 Enrichment at Genestac Therapeutics

At Genestac Therapeutics, we provide advanced CD34 Enrichment services for stem cell therapy and regenerative medicine. Our expertise ensures:

• High-yield stem cell recovery
• Customized cell dosing for patients
• Immune profiling and diagnostics
• Safe infusion with post-therapy monitoring

Conclusion

CD34 Enrichment is transforming the future of regenerative medicine by improving the precision and outcomes of stem cell therapy. With Genestac’s innovation and clinical expertise, patients gain access to cutting-edge solutions for blood disorders, neurological conditions, and cardiovascular repair.

Frequently Asked Questions (FAQs)